Languages: English / Copyright: Public domain / Dates by Range: 2000 and later - Digital Collections - National Library of Medicine Search Results

Start Over Languages English ✖ Copyright Public domain ✖ Dates by Range 2000 and later ✖ Publication Year 2020 to 2021 ✖

31. A pathway to full integration of care for Medicare-Medicaid beneficiaries

Publication:: Washington, DC : Bipartisan Policy Center, July 2020
Subject(s):: Delivery of Health Care, Integrated
Dual MEDICAID MEDICARE Eligibility
United States

32. Providing stable, healthy, and affordable rental housing through the COVID-19 crisis

Publication:: Washington, D.C. : Bipartisan Policy Center, September 2020
Subject(s):: COVID-19 -- economics
Housing -- economics
United States

33. Tracking FY2019 federal funding to combat the opioid crisis

Publication:: Washington, D.C. : Bipartisan Policy Center, September 2020
Subject(s):: Opiate Overdose -- mortality
Opioid Epidemic -- prevention & control
Opioid Epidemic -- statistics & numerical data
COVID-19
United States

34. Improving opportunities for working people with disabilities

Publication:: Washington, D.C. : Bipartisan Policy Center, January 2021
Subject(s):: Disabled Persons
Medicaid -- legislation & jurisprudence
Medicaid -- organization & administration
Dual MEDICAID MEDICARE Eligibility
Social Security
United States

35. COVID-19: urgent federal actions to accelerate America's response

Publication:: Washington, D.C. : Bipartisan Policy Center, January 2021
Subject(s):: COVID-19 -- prevention & control
COVID-19 Testing
COVID-19 Vaccines -- supply & distribution
Healthcare Disparities
United States

36. Pathological complete response in neoadjuvant treatment of high-risk early-stage breast cancer: use as an endpoint to support accelerated approval

Publication:: [Silver Spring, MD] : United States Food and Drug Administration, Oncology Center of Excellence, July 2020
Subject(s):: Breast Neoplasms
Clinical Trials as Topic
Neoadjuvant Therapy
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

37. Enforcement policy for viral transport media during the Coronavirus disease 2019 (COVID-19) public health emergency: guidance for commercial manufacturers, clinical laboratories, and Food and Drug Administration staff

Publication:: [Silver Spring, MD] : Center for Devices and Radiological Health, Office of Product Evaluation and Quality, July 2020
Subject(s):: Culture Media
Specimen Handling
Transportation
Virus Diseases
COVID-19
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

38. Regulatory considerations for human cells, tissues, and cellular and tissue-based products: minimal manipulation and homologous use : guidance for industry and Food and Drug Administration staff

Publication:: Silver Spring, MD : Center for Biologics Evaluation and Research, July 2020
Subject(s):: Biological Products
Tissues
Cell- and Tissue-Based Therapy
Tissue Transplantation
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

39. Cancer clinical trial eligibility criteria: minimum age considerations for inclusion of pediatric patients : guidance for industry and IRBs

Publication:: Silver Spring, MD : United States Food and Drug Administration, Oncology Center of Excellence, July 2020
Subject(s):: Clinical Trials as Topic
Eligibility Determination
Neoplasms
Pediatrics
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

40. Cancer clinical trial eligibility criteria: brain metastases

Publication:: Silver Spring, MD : Food and Drug Administration, Oncology Center of Excellence, July 2020
Subject(s):: Brain Neoplasms
Clinical Trials as Topic
Eligibility Determination
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

« Previous
Next »
1
2
3
4
5
6
7
8
…
51
52